Vanderbilt — Nashville, Tennessee

Vanderbilt is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Vanderbilt has participated in 43 clinical trials with 7 currently active.

Therapeutic areas: Idiopathic Pulmonary Fibrosis, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia.

Sponsors: Weill Medical College of Cornell University, Astex Pharmaceuticals, Inc., Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt?

Vanderbilt has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt conducted?

Vanderbilt has 43 clinical trials on record, with 7 currently active. Their work covers Idiopathic Pulmonary Fibrosis, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia.

Is Vanderbilt accredited by Crixeo Health?

Vanderbilt has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.